• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDACTA INTERNATIONAL SA AMISTEM H HA COATED STD STEM SIZE 2; HIP CEMENTLESS STEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDACTA INTERNATIONAL SA AMISTEM H HA COATED STD STEM SIZE 2; HIP CEMENTLESS STEM Back to Search Results
Catalog Number 01.18.132
Medical Device Problem Code Osseointegration Problem (3003)
Health Effect - Clinical Code Inadequate Osseointegration (2646)
Date of Event 04/18/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Batch review performed on 30 april 2024: lot 157869: (b)(4) items manufactured and released on 26-apr-2016.Expiration date: 2021-04-20.No anomalies found related to the problem.To date, all items of the same lot have been sold without any similar reported event during the period of review.Explants images analysis performed by medacta hip r&d project manager: looking at the images attached to the complaint only proximal half of the stem is visible.On the body no white film residuals are visible.Absorption of ha from the stem body can indicate that metabolic activity was taking place and that, presumably, adequate bone contact was achieved at the time of surgery.The post-op x-ray analysis could possibly provide more insight, such as the evaluation of possible early rotational instability or initial stress-shielding.Some signs of damage and scratches are present on the neck of the explanted stem, which is likely due to the revision surgery and not relevant to the reported issue.Based on the analysis completed and information available, it is not possible to identify a root cause of the stem loosening reported.Clinical evaluation performed by medacta medical affairs manager: revision surgery about 8 years after primary tha due to stem loosening.From the radiographic image, radiolucent lines along the stem are visible.Aseptic loosening is a possible literature described adverse event after primary cementless hip arthroplasties and causes are often unknown.However, the very neat demarcation lines suggest the possibility of a negative reaction of bone to implant, such as an osteolytic process or local infection, but no information is available on these possibilities.No definite cause could be determined for this adverse event.
 
Event or Problem Description
Revision surgery due to stem loosening, at about 8 years after primary.Stem, head and insert successfully revised.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMISTEM H HA COATED STD STEM SIZE 2
Common Device Name
HIP CEMENTLESS STEM
Manufacturer (Section D)
MEDACTA INTERNATIONAL SA
strada regina
castel san pietro, switzerland 6874
SZ  6874
Manufacturer (Section G)
MEDACTA INTERNATIONAL SA
strada regina
castel san pietro, switzerland 6874
SZ   6874
Manufacturer Contact
marco giannessi
strada regina
castel san pietro, switzerland 6874
SZ   6874
MDR Report Key19297227
Report Number3005180920-2024-00331
Device Sequence Number6834461
Product Code LZO
UDI-Device Identifier07630030804083
UDI-Public07630030804083
Combination Product (Y/N)N
Initial Reporter CountrySZ
PMA/510(K) Number
K093944
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2016
Device Explanted Year2024
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 05/13/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date04/20/2021
Device Catalogue Number01.18.132
Device Lot Number157869
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/18/2024
Initial Report FDA Received Date05/13/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured04/26/2016
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age86 YR
Patient SexFemale
-
-